The largest database of trusted experimental protocols

Trimethoprim sulfamethoxazole tmp smx

Manufactured by Merck Group
Sourced in Canada, Sao Tome and Principe

Trimethoprim/sulfamethoxazole (TMP/SMX) is a combination antibiotic medication used to treat various bacterial infections. It consists of two active ingredients, trimethoprim and sulfamethoxazole, which work together to inhibit the growth and reproduction of bacteria.

Automatically generated - may contain errors

2 protocols using trimethoprim sulfamethoxazole tmp smx

1

Antimicrobial Substance Preparation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pure substance pradofloxacin was obtained from Bayer Animal Health (Elanco, as of 2020) and prepared as per the manufacturer’s instructions. Ampicillin (Auro Pharma, Woodbridge, ON, Canada), cephalexin (Novapharm, Scarborough, ON, Canada), marbofloxacin (Zoetis, Kirkland, QC, Canada), and trimethoprim/sulfamethoxazole (TMP/SMX) (Sigma Aldrich, Oakville, ON, Canada) were purchased commercially and prepared in accordance with the manufacturer’s directions. Fresh stock solutions or samples stored at −70 °C were used for each experiment.
+ Open protocol
+ Expand
2

Pneumococcal Isolate Identification and Antimicrobial Susceptibility

Check if the same lab product or an alternative is used in the 5 most similar protocols
Once in the laboratory, pneumococcal isolates were reidentified by standard procedures that included tests for bile solubility and optochin sensitivity. Pneumococcal isolates were serotyped by the Quellung reaction with type-and factor-specific antisera (Statens Serum Institut, Copenhagen, Denmark). Antimicrobial susceptibility tests for penicillin, cefotaxime, vancomycin, erythromycin, chloramphenicol and trimethoprim/sulfamethoxazole (TMP/SMX) all from Sigma-Aldrich, (St Louis MO,US) were performed by the broth microdilution method to determine the minimum inhibitory concentration (MIC) and clinical interpretation according to the procedures of the Clinical and Laboratory Standards Institute (CLSI) using cation-adjusted Mueller-Hinton broth (CAMHB) supplemented with 3% lysed horse blood. Interpretative criteria were differentiated for meningitis and non-meningitis isolates to penicillin and cefotaxime according to CLSI. S. pneumoniae ATCC 49619 was used as the control strain. 5
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!